The identification of OCT4-driven plasticity in enzalutamide-resistant cells highlights its role as a key mediator of therapy-induced lineage plasticity, making it a promising target for overcoming treatment resistance in PCa [36]. Here, POU5F1 is linked to posterior cortical atrophy.